Author: Nichols Martin|| Date Published: February 2, 2021
Ellume has been awarded a $231.8 million contract by the departments of Defense and Health and Human Services to manufacture 8.5 million at-home tests for COVID-19.
DOD said Monday the funds will help the company increase its production capacity for coronavirus diagnostic tests by 640,000 each day through December.
The U.S. government will distribute Ellume-made kits as part of the National Strategy for the COVID-19 Response and Pandemic Preparedness mandate.
The Food and Drug Administration gave emergency use authorization to the company for its test kit to be sold over the counter and to provide results to users within 15 minutes via a smartphone application.
Ellume developed its product via the National Institutes of Health-backed Rapid Acceleration of Diagnostics initiative.
The Naval Information Warfare Center Pacific is soliciting proposals for the development and fielding of intelligence, surveillance and reconnaissance systems…
The Department of War is accelerating its push into unmanned systems, moving beyond experimentation toward large-scale production, streamlined acquisition and…
BAE Systems has received a $117.7 million contract modification from the U.S. Navy to support depot-level modernization, maintenance and repair of USS…
Advanced wireless infrastructure is becoming as strategically important as artificial intelligence in modern defense operations 5G standalone enables network slicing,…
